Paxil linked to birth defects

Glaxo-Smith-Kline says its anti-depressant Paxil "may" be linked more often to birth defects than similar drugs.

In a new study, women exposed to Paxil or other antidepressants during the first trimester suggested an increased risk of major congenital malformations among women taking Paxil.

GSK is adding the information to Paxil's label and sending letters to doctors.

GSK adds that an even larger study by the Swedish medical birth registry found no increased risk for overall malformations among women taking Paxil.

WTVY-TV 285 N Foster Street Dothan, AL 36303 334-792-3195
Copyright © 2002-2016 - Designed by Gray Digital Media - Powered by Clickability 1763121 -
Gray Television, Inc.